Francois P. Vandervegt

Array ( [id] => 6846890 [patent_doc_number] => 20030166057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Method and apparatus for the production of soluble MHC antigens and uses thereof' [patent_app_type] => new [patent_app_number] => 10/022066 [patent_app_country] => US [patent_app_date] => 2001-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 98 [patent_figures_cnt] => 98 [patent_no_of_words] => 47923 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166057.pdf [firstpage_image] =>[orig_patent_app_number] => 10022066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 951239 [patent_doc_number] => 06960441 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-11-01 [patent_title] => 'Assays for the detection of human defensin polypeptide (Def-X)' [patent_app_type] => utility [patent_app_number] => 10/013770 [patent_app_country] => US [patent_app_date] => 2001-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 17 [patent_no_of_words] => 9587 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/960/06960441.pdf [firstpage_image] =>[orig_patent_app_number] => 10013770 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6278399 [patent_doc_number] => 20020107180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-08 [patent_title] => 'Cell surface glycoproteins' [patent_app_type] => new [patent_app_number] => 09/997701 [patent_app_country] => US [patent_app_date] => 2001-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 21857 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20020107180.pdf [firstpage_image] =>[orig_patent_app_number] => 09997701 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 823804 [patent_doc_number] => 07405276 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-29 [patent_title] => 'Method of producing bispecific molecules by protein trans-splicing' [patent_app_type] => utility [patent_app_number] => 10/415840 [patent_app_country] => US [patent_app_date] => 2001-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 21553 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/405/07405276.pdf [firstpage_image] =>[orig_patent_app_number] => 10415840 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6017614 [patent_doc_number] => 20020103343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-01 [patent_title] => 'Antigen-based heteropolymers and method for treating autoimmune diseases using the same' [patent_app_type] => new [patent_app_number] => 10/016763 [patent_app_country] => US [patent_app_date] => 2001-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 5545 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20020103343.pdf [firstpage_image] =>[orig_patent_app_number] => 10016763 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 218918 [patent_doc_number] => RE040948 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2009-10-27 [patent_title] => 'APC antibodies' [patent_app_type] => reissue [patent_app_number] => 09/983543 [patent_app_country] => US [patent_app_date] => 2001-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 42 [patent_no_of_words] => 17687 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/040/RE040948.pdf [firstpage_image] =>[orig_patent_app_number] => 09983543 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 658828 [patent_doc_number] => 07105651 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-09-12 [patent_title] => 'Nucleic acids and vectors encoding human defensin polypeptide and applications thereof' [patent_app_type] => utility [patent_app_number] => 10/045180 [patent_app_country] => US [patent_app_date] => 2001-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 5 [patent_no_of_words] => 9561 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/105/07105651.pdf [firstpage_image] =>[orig_patent_app_number] => 10045180 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6659598 [patent_doc_number] => 20030134430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-17 [patent_title] => 'Novel amino acid sequences for human caenorhabditis elegans-like protein polypeptides' [patent_app_type] => new [patent_app_number] => 09/977751 [patent_app_country] => US [patent_app_date] => 2001-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 55622 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20030134430.pdf [firstpage_image] =>[orig_patent_app_number] => 09977751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6326573 [patent_doc_number] => 20020197672 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-26 [patent_title] => 'Comparative ligand mapping from MHC positive cells' [patent_app_type] => new [patent_app_number] => 09/974366 [patent_app_country] => US [patent_app_date] => 2001-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 19021 [patent_no_of_claims] => 144 [patent_no_of_ind_claims] => 32 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20020197672.pdf [firstpage_image] =>[orig_patent_app_number] => 09974366 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6406227 [patent_doc_number] => 20020182671 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-05 [patent_title] => 'Membrane associated proteins' [patent_app_type] => new [patent_app_number] => 09/965529 [patent_app_country] => US [patent_app_date] => 2001-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38782 [patent_no_of_claims] => 129 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20020182671.pdf [firstpage_image] =>[orig_patent_app_number] => 09965529 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6519184 [patent_doc_number] => 20020192212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Uses of anti-CX3CR1 antibody, anti-fractalkine antibody and fractalkine' [patent_app_type] => new [patent_app_number] => 09/963316 [patent_app_country] => US [patent_app_date] => 2001-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8951 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20020192212.pdf [firstpage_image] =>[orig_patent_app_number] => 09963316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6829250 [patent_doc_number] => 20030180308 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Deglycosylated ricin toxin a-chain vaccine' [patent_app_type] => new [patent_app_number] => 09/960315 [patent_app_country] => US [patent_app_date] => 2001-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 15755 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20030180308.pdf [firstpage_image] =>[orig_patent_app_number] => 09960315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 875936 [patent_doc_number] => 07358087 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-15 [patent_title] => 'Compositions and methods for enhancing immune responses mediated by antigen-presenting cells' [patent_app_type] => utility [patent_app_number] => 09/954349 [patent_app_country] => US [patent_app_date] => 2001-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14232 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 179 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/358/07358087.pdf [firstpage_image] =>[orig_patent_app_number] => 09954349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5827935 [patent_doc_number] => 20020068053 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-06 [patent_title] => 'Process for the production of anti-tumor Th1 cells' [patent_app_type] => new [patent_app_number] => 09/932575 [patent_app_country] => US [patent_app_date] => 2001-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3537 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20020068053.pdf [firstpage_image] =>[orig_patent_app_number] => 09932575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6740336 [patent_doc_number] => 20030157705 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Engineered recombinant molecule that regulates humoral and cellular effector functions of the immune system' [patent_app_type] => new [patent_app_number] => 09/928267 [patent_app_country] => US [patent_app_date] => 2001-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 12769 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20030157705.pdf [firstpage_image] =>[orig_patent_app_number] => 09928267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 919582 [patent_doc_number] => 07320873 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-22 [patent_title] => 'Use of antibodies against specific MHC-peptide complexes' [patent_app_type] => utility [patent_app_number] => 10/344872 [patent_app_country] => US [patent_app_date] => 2001-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 6 [patent_no_of_words] => 7738 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/320/07320873.pdf [firstpage_image] =>[orig_patent_app_number] => 10344872 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6328993 [patent_doc_number] => 20020198144 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-26 [patent_title] => 'MHC complexes and uses thereof' [patent_app_type] => new [patent_app_number] => 09/900379 [patent_app_country] => US [patent_app_date] => 2001-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 64 [patent_figures_cnt] => 64 [patent_no_of_words] => 35245 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20020198144.pdf [firstpage_image] =>[orig_patent_app_number] => 09900379 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5999265 [patent_doc_number] => 20020028203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-07 [patent_title] => 'T cell inhibitory receptor compositions and uses thereof' [patent_app_type] => new [patent_app_number] => 09/884196 [patent_app_country] => US [patent_app_date] => 2001-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13147 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20020028203.pdf [firstpage_image] =>[orig_patent_app_number] => 09884196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 695748 [patent_doc_number] => 07071299 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-07-04 [patent_title] => 'Peptide and polypeptide inhibitors of complement C1s' [patent_app_type] => utility [patent_app_number] => 09/883727 [patent_app_country] => US [patent_app_date] => 2001-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18053 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/071/07071299.pdf [firstpage_image] =>[orig_patent_app_number] => 09883727 [rel_patent_id] =>[rel_patent_doc_number] =>)